Name: Latest research reports of Colgate-Palmolive (India) Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Colgate-Palmolive (India) Ltd.
Rating: 4
Author: ICICI Securities Limited

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	10 Sep 2025	Colgate-Palmolive	Consensus Share Price Target	2402.20	2522.65	-	5.01	hold	pdf Detailed Estimates
	14 May 2023	Colgate-Palmolive	ICICI Securities Limited Target	2402.20	1750.00	1627.70 (47.58%)	Target met	Accumulate	pdf post cache	Broker Report Focus on core to (potentially) re-ignite volume growth ICICI Securities Limited 4QFY23 was in line with our estimates, but likely beat consensus. Recovery in revenue growth was modest and driven by price hike while volumes declined ~1% (albeit better than overall category decline). pdf Copy Link Share on Share on Share on Share on Alert
	13 May 2023	Colgate-Palmolive	ICICI Direct Target	2402.20	1560.00	1627.70 (47.58%)		Hold	pdf post cache	Broker Report Colgate Palmolive India ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	12 May 2023	Colgate-Palmolive	Sharekhan	2402.20	1515.00	1673.65 (43.53%)		Sell	pdf post cache	Broker Report Colgate Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	02 Feb 2023	Colgate-Palmolive	Geojit BNP Paribas Target	2402.20	1580.00	1461.45 (64.37%)	Target met	Hold	pdf post cache	Broker Report COLGATE PALMOLIVE INDIA LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	25 Jan 2023	Colgate-Palmolive	Axis Direct Reco Target	2402.20	1550.00	1451.20 (65.53%)	Target met	Hold	pdf post cache	Broker Report Result Update:Colgate-Palmoliv Axis Direct With a limited upside potential from the CMP, we ascribe a HOLD rating on the stock. pdf Copy Link Share on Share on Share on Share on Alert
	25 Jan 2023	Colgate-Palmolive	ICICI Securities Limited Target	2402.20	1650.00	1459.25 (64.62%)	Target met	Accumulate	pdf post cache	Broker Report Another new year, another underwhelming revenue performance ICICI Securities Limited 3QFY23 revenues growth of 0.8% YoY was again underwhelming but not unexpected. However, increase in ad-spends by 13% YoY to 13.2% (+140bps YoY) is the only encouraging (somewhat) outcome. pdf Copy Link Share on Share on Share on Share on Alert
	24 Jan 2023	Colgate-Palmolive	Motilal Oswal	2402.20	1565.00	1459.25 (64.62%)	Target met	Neutral	pdf post cache	Broker Report Flat sales lead to earnings miss Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	21 Oct 2022	Colgate-Palmolive	Axis Direct Target	2402.20	1750.00	1586.85 (51.38%)	Target met	Buy	pdf post cache	Broker Report Result Update:Colgate-Palmoliv Axis Direct Maintain BUY rating on the stock with a revised TP of Rs1,750 at 39x FY24E EPS. Key risk increase in competitive intensity, prolonged rural recovery and higher raw material inflation. pdf Copy Link Share on Share on Share on Share on Alert
	21 Oct 2022	Colgate-Palmolive	ICICI Securities Limited Target	2402.20	1750.00	1605.05 (49.67%)	Target met	Accumulate	pdf post cache	Broker Report No surprises. Another year, another weak quarter, as usual ICICI Securities Limited 2QFY23 revenues growth of 2.6% YoY was again underwhelming but not unexpected. pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2022	Colgate-Palmolive	Prabhudas Lilladhar Target	2402.20	1701.00	1548.85 (55.10%)	Target met	Accumulate	pdf post cache	Broker Report COLGATE PALMOLIVE IN Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
more loading

38.25% Fall from 52W High

Colgate-Palmolive (India) Ltd. share price target

Colgate-Palmolive (India) Ltd. has an average share price target of 2647.38. The consensus estimate represents an upside of 10.21% from the last price of 2402.20. View 17 reports from 8 analysts offering long-term price targets for Colgate-Palmolive (India) Ltd..

Focus on core to (potentially) re-ignite volume growth

Colgate Palmolive India

Colgate

COLGATE PALMOLIVE INDIA LTD

Result Update:Colgate-Palmoliv

Another new year, another underwhelming revenue performance

Flat sales lead to earnings miss

Result Update:Colgate-Palmoliv

No surprises. Another year, another weak quarter, as usual

COLGATE PALMOLIVE IN

Advisor Screeners